NCT07238075 2026-02-17
ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
Adcytherix SAS
Phase 1 Recruiting
Adcytherix SAS
Shanghai Juncell Therapeutics
Guangzhou FineImmune Biotechnology Co., LTD.
Guangzhou FineImmune Biotechnology Co., LTD.
Aminex Therapeutics, Inc.